Showing results (101-110 of 428) with videos related to
Sort By:
Pageof 43
Journal of Neuroscience Research|July 21, 2004
Three putative N-glycosylation sites within the murine 5-HT3A receptor sequence affect plasma membrane targeting, ligand binding, and calcium influx in heterologous mammalian cellsPhillip L Quirk, Suma Rao, Bryan L Roth, et al.Biochemistry|January 22, 2008
Galpha-subunits differentially alter the conformation and agonist affinity of kappa-opioid receptorsFeng Yan, Philip D Mosier, Richard B Westkaemper, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2007
Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and BRuslan V Bikbulatov, Feng Yan, Bryan L Roth, et al.Science Signaling|April 7, 2021
Biased ligands at opioid receptors: Current status and future directionsTao Che, Hemlata Dwivedi-Agnihotri, Arun K Shukla, et al.Drug Discovery Today|December 5, 2023
Illuminating the understudied GPCR-omeSreeparna Majumdar, Yi-Ting Chiu, Julie E Pickett, et al.Pharmacology & Therapeutics|March 29, 2011
Serotonin receptors and heart valve disease--it was meant 2BJoshua D Hutcheson, Vincent Setola, Bryan L Roth, et al.European Journal of Pharmacology|December 9, 2003
Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonistSrinivas Peddi, Bryan L Roth, Richard A Glennon, et al.Nature Methods|January 8, 2013
A pharmacological organization of G protein-coupled receptorsHenry Lin, Maria F Sassano, Bryan L Roth, et al.Molecular Pharmacology|April 16, 2003
The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalizationJohn A Gray, Anushree Bhatnagar, Vsevolod V Gurevich, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA)Srinivas Peddi, Bryan L Roth, Richard A Glennon, et al.Pageof 43